How have MDRSF shares performed in 2024?

Medartis' stock was trading at C$77.96 at the start of the year. Since then, MDRSF shares have increased by 0.0% and is now trading at C$77.96. View the best growth stocks for 2024 here .

Are investors shorting Medartis?

Medartis saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 2,700 shares, an increase of 22.7% from the February 29th total of 2,200 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ∞ days. View Medartis' Short Interest .

How do I buy shares of Medartis?

Shares of MDRSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:MDRSF

Medartis (MDRSF) Stock Price, News & Analysis

→ Could Bitcoin Literally FORCE This Crypto To Rocket Up? (From Paradigm Press) (Ad)

Free MDRSF Stock Alerts

C$77.96

0.00 (0.00%)

(As of 04/17/2024 ET)

Compare

Today's Range: C$77.96
▼
C$77.96
50-Day Range: C$77.96
▼
C$77.96
52-Week Range: C$73.86
▼
C$77.96

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Short Interest

Get Medartis alerts:

Ad Paradigm Press

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

About Medartis Stock (OTCMKTS:MDRSF)

Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. It serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. The company was founded in 1997 and is headquartered in Basel, Switzerland.

MDRSF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

MDRSF Stock News Headlines

March 6, 2024 | morningstar.com

SIG Group AG Ordinary Shares SIGN

February 16, 2024 | morningstar.com

Medartis Holding AG Ordinary Shares

April 17, 2024 | Paradigm Press (Ad)

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

September 19, 2023 | jp.reuters.com

Medartis Holding AG

July 17, 2023 | investing.com

Medartis Holding AG (MEDA)

May 31, 2023 | fool.com

American Well (NYSE: AMWL)

May 18, 2023 | finance.yahoo.com

Sentiment Still Eluding Medartis Holding AG (VTX:MED)

See More Headlines

Receive MDRSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medartis and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Medical Devices
Sub-Industry: N/A
Current Symbol: OTCMKTS:MDRSF
CUSIP: N/A
CIK: N/A
Web: www.medartis.com
Phone: 41 61 633 34 34
Fax: N/A
Employees: 747
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

Dr. Christoph Bronnimann (Age 58)
CEO & Member of Executive Management Board
Comp: $1.51M
Dr. Thomas Straumann (Age 61)
Founder & Vice Chairman
Comp: $323.06k
Dr. Dirk W. Kirsten (Age 56)
CFO & Member of the Executive Management Board
Mr. Fabian Hildbrand
Head of Corporate Communications
Ms. Anisha Wharton
Head of Regulatory Affairs

Key Competitors

View All Competitors

MDRSF Stock Analysis - Frequently Asked Questions

How have MDRSF shares performed in 2024?: Medartis' stock was trading at C$77.96 at the start of the year. Since then, MDRSF shares have increased by 0.0% and is now trading at C$77.96.
View the best growth stocks for 2024 here.
Are investors shorting Medartis?: Medartis saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 2,700 shares, an increase of 22.7% from the February 29th total of 2,200 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ∞ days.
View Medartis' Short Interest.
How do I buy shares of Medartis?: Shares of MDRSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:MDRSF) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial